
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-07-18 | 2024-07-18 | 2024-07-18 | |||
Income Statement | ||||||
Revenue | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
Diluted EPS | -- | -- | -- | -- | -- |
Period Ending | 2017-01-31 | 2018-01-31 | 2019-01-31 | 2020-01-31 | 2021-01-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | -- | $37.2M | $29.8M | $74.4M | $48.2M | |
Total Assets | -- | $791.6M | $730.5M | $855.4M | $903.8M | |
Current Liabilities | -- | $129.8M | $103.8M | $229.6M | $291.2M | |
Total Liabilities | -- | $135.9M | $110.4M | $239.6M | $301.5M | |
Total Equity | -- | $655.6M | $620.1M | $615.9M | $602.3M | |
Total Debt | -- | -- | -- | -- | -- |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-07-18 | 2024-07-18 | 2024-07-18 | |||
Cash Flow Statement | ||||||
Cash Flow Operations | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Free Cash Flow | -- | -- | -- | -- | -- |
PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income with capital appreciation as a secondary objective. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.
In the current month, PCN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PCN average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that PIMCO Corporate & Income Strategy Fund share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about PIMCO Corporate & Income Strategy Fund share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PIMCO Corporate & Income Strategy Fund is a Sell and believe this share price will rise from its current level to --.
The price target for PIMCO Corporate & Income Strategy Fund over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for PIMCO Corporate & Income Strategy Fund is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of PIMCO Corporate & Income Strategy Fund via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PIMCO Corporate & Income Strategy Fund shares.
PIMCO Corporate & Income Strategy Fund was last trading at $12.55 per share. This represents the most recent stock quote for PIMCO Corporate & Income Strategy Fund. Yesterday, PIMCO Corporate & Income Strategy Fund closed at $12.52 per share.
In order to purchase PIMCO Corporate & Income Strategy Fund stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.